PRospective Evaluation of a prediction score Determining Individual Clinical outcome Three months after Juvenile Stroke

• Conditions: I63; I64; G45; Cerebral infarction; Stroke, not specified as haemorrhage or infarction; Transient cerebral ischaemic attacks and related syndromes

• Registration Number: DRKS00024407
• Lead Sponsor: eurologische Klinik und Poliklinik, LMU Klinikum, LMU München

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-03-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 430

Inclusion Criteria

I 01. Male and female juvenile stroke patients aged 18 to 55 years and older stroke patients >55 years

I 02. Written informed consent by the patient, if capable, or their legal representatives, if available, obtained at the latest prior to the three months follow-up visit.

Exclusion Criteria

E 01. The patient is directly involved in the conduct of the protocol: the investigator or subinvestigator, research assistant, pharmacist, study coordinator, other staff or relatives thereof.

E 02. Refusal of consent, in patients/legal representatives capable of giving informed consent.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To validate a prediction score for a good outcome (mRS 0-2 or back to baseline) three months after juvenile stroke by assessing its discrimination using the AUC of the ROC (H0: AUC < 0.7)